ARTICLE | Clinical News
LAX-101: Phase III started
January 18, 2010 8:00 AM UTC
Amarin began the double-blind, international Phase III MARINE trial (Study 16) to evaluate 2 and 4 g of twice-daily, oral AMR101 vs. placebo in about 240 patients with fasting triglyceride levels >=50...